Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5998
+0.0201 (3.47%)
Sep 2, 2025, 4:00 PM - Market closed

Impact BioMedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
717----
Upgrade
Enterprise Value
2925----
Upgrade
Last Close Price
0.581.45----
Upgrade
PB Ratio
-2.31----
Upgrade
Debt / Equity Ratio
-3.031.230.430.310.310.03
Upgrade
Asset Turnover
0--0.00--
Upgrade
Quick Ratio
0.030.200.0100.000.07
Upgrade
Current Ratio
0.060.250.030.010.020.10
Upgrade
Return on Equity (ROE)
-405.44%-139.55%-14.46%-19.99%-4.52%-3.89%
Upgrade
Return on Assets (ROA)
-8.24%-6.54%-5.53%-4.13%-3.81%-2.32%
Upgrade
Return on Capital (ROIC)
-9.50%-7.52%-6.07%-4.47%-4.18%-2.61%
Upgrade
Earnings Yield
-534.23%-148.12%----
Upgrade
FCF Yield
-61.49%-23.49%----
Upgrade
Buyback Yield / Dilution
60.59%82.14%14.54%0.00%--
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q